Gri bio to present at the 8th annual ipf summit

La jolla, ca, july 01, 2024 (globe newswire) -- gri bio, inc. (nasdaq: gri) (“gri bio” or the “company”), a biotechnology company advancing an innovative pipeline of natural killer t (“nkt”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that vipin kumar chaturvedi, phd, chief scientific officer of gri bio , will present at the 8 th annual ipf summit taking place august 20-22, 2024 in boston, ma.
GRI Ratings Summary
GRI Quant Ranking